Press Releases | Association for Accessible Medicines

Bloomberg - Read the article "Why We May Lose Generic Drugs"

Apr 18, 2018 | Rachel Schwartz

AAM Announces 2018 Associate Members

Apr 18, 2018 | Rachel Schwartz

AAM Announces New Board Member and Additional Members

Apr 13, 2018 | Rachel Schwartz

AAM Statement on U.S. Court of Appeals Ruling on Maryland HB 631

ASAE Announces 2018 Gold Circle Award Winners

Apr 11, 2018 | Rachel Schwartz

AAM Receives Two ASAE 2018 Gold Circle Awards

Apr 9, 2018 | Rachel Schwartz

AAM Launches Code of Business Ethics

AAM - Your Generics & Biosimilars Industry

Apr 4, 2018 | Rachel Schwartz

AAM Statement on China Tariffs

Mar 28, 2018 | Rachel Schwartz

AAM Statement on Generic and Biosimilar Drugmaker Inability to Acquire Samples

CREATES Act Statement - Capitol Building, DC

Mar 20, 2018 | Rachel Schwartz

AAM Statement — Restricting Patent Settlements Hurts Patients

STAT: Grassley, Leahy

Mar 16, 2018 | Rachel Schwartz

Op-Ed from STAT — Grassley, Leahy: It's Time to Empower Generic Drug Makers to Bring Down Prices

AAM Statement on PACED Act of 2018

Mar 8, 2018 | Rachel Schwartz

AAM Statement on PACED Act of 2018

White Paper: Ensuring the Future of Accessible Medicines in the US

Feb 12, 2018 | Rachel Schwartz

White Paper: Ensuring the Future of Accessible Medicines in the U.S.

Feb 12, 2018 | Rachel Schwartz

AAM Announces 2018 Board of Directors